Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (491-500 of 547) with videos related to

Pageof 55
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|November 6, 2025
GPR68, A Proton-sensing GPCR, Mediates Acid-induced Visceral NociceptionLuke W Paine, Rohit Gupta, James P Higham, et al.
The American Journal of Gastroenterology|September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION TrialSilvio Danese, Marc Ferrante, Brian G Feagan, et al.
Therapeutic Advances in Gastroenterology|February 14, 2022
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in SwitzerlandKathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, et al.
United European Gastroenterology Journal|July 19, 2019
Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the diseasePhilipp Schreiner, Bahtiyar Yilmaz, Jean-Benoît Rossel, et al.
Journal of Crohn'S & Colitis|October 7, 2016
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's DiseaseJürgen Schölmerich, Klaus Fellermann, Frank W Seibold, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situationsGert Van Assche, Axel Dignass, Bernd Bokemeyer, et al.
BMC Gastroenterology|January 9, 2019
The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammationIrina V Tcymbarevich, Jyrki J Eloranta, Jean-Benoît Rossel, et al.
Journal of Crohn'S & Colitis|November 15, 2017
The Proton-activated Receptor GPR4 Modulates Intestinal InflammationYu Wang, Cheryl de Vallière, Pedro H Imenez Silva, et al.
Mucosal Immunology|September 11, 2019
Loss of PTPN22 abrogates the beneficial effect of cohousing-mediated fecal microbiota transfer in murine colitisMarianne R Spalinger, Marlene Schwarzfischer, Larissa Hering, et al.
European Journal of Gastroenterology & Hepatology|November 1, 2022
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the diseaseMaude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, et al.
Pageof 55

Showing results (491-500 of 547) with videos related to

Sort By:
Pageof 55
Cellular and Molecular Gastroenterology and Hepatology|November 6, 2025
GPR68, A Proton-sensing GPCR, Mediates Acid-induced Visceral NociceptionLuke W Paine, Rohit Gupta, James P Higham, et al.
The American Journal of Gastroenterology|September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION TrialSilvio Danese, Marc Ferrante, Brian G Feagan, et al.
Therapeutic Advances in Gastroenterology|February 14, 2022
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in SwitzerlandKathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, et al.
United European Gastroenterology Journal|July 19, 2019
Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the diseasePhilipp Schreiner, Bahtiyar Yilmaz, Jean-Benoît Rossel, et al.
Journal of Crohn'S & Colitis|October 7, 2016
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's DiseaseJürgen Schölmerich, Klaus Fellermann, Frank W Seibold, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situationsGert Van Assche, Axel Dignass, Bernd Bokemeyer, et al.
BMC Gastroenterology|January 9, 2019
The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammationIrina V Tcymbarevich, Jyrki J Eloranta, Jean-Benoît Rossel, et al.
Journal of Crohn'S & Colitis|November 15, 2017
The Proton-activated Receptor GPR4 Modulates Intestinal InflammationYu Wang, Cheryl de Vallière, Pedro H Imenez Silva, et al.
Mucosal Immunology|September 11, 2019
Loss of PTPN22 abrogates the beneficial effect of cohousing-mediated fecal microbiota transfer in murine colitisMarianne R Spalinger, Marlene Schwarzfischer, Larissa Hering, et al.
European Journal of Gastroenterology & Hepatology|November 1, 2022
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the diseaseMaude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, et al.
Pageof 55